AnalystsMichael FreemanMichael Freeman's Stock Forecasts
AnalystsMichael Freeman
Sectors:
Analyst Ranking
Bottom 36%
#3558 out of 5504 analysts
Average Return
+0.03%
Win Rate
67%4 out of 6
Risk vs Reward
Poor
Good
Michael Freeman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Disc Medicine IncIRON | +32.23% | $50.86 | $67.25 | 2025-06-11 - 2026-06-10 | Strong Buy |
Dyne Therapeutics IncDYN | +21.28% | $14.57 | $17.67 | 2025-06-11 - 2026-06-10 | Buy |
Tectonic Therapeutic IncTECX | +19.36% | $23.50 | $28.05 | 2025-06-11 - 2026-06-10 | Buy |
Tectonic Therapeutic IncTECX | +2.53% | $29.99 | $30.75 | 2026-05-26 - 2026-09-04 | Strong Buy |
Michael Freeman Analyst Color
Get additional color on Michael Freeman's coverage of popular stocks
Michael Freeman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tectonic Therapeutic IncTECX | 2 | Strong Buy | $81.00 | +163.41% | Upgrades | 3 months ago |
Wave Life Sciences IncWVE | 1 | Buy | $14.00 | N/A | Assumes | a year ago |
Dyne Therapeutics IncDYN | 1 | Buy | $37.00 | N/A | Assumes | a year ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | N/A | Reinstates | a year ago |
Avidity Biosciences IncRNAM | 1 | Strong Buy | $65.00 | N/A | Initiates Coverage On | a year ago |
Bausch Health Companies IncBHC | 1 | Hold | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.